Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,021 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study.
Hiratsuka Y, Tagami K, Inoue A, Sato M, Matsuda Y, Kosugi K, Kubo E, Natsume M, Ishiki H, Arakawa S, Shimizu M, Yokomichi N, Chiu SW, Shimoda M, Hirayama H, Nishijima K, Ouchi K, Shimoi T, Shigeno T, Yamaguchi T, Miyashita M, Morita T, Satomi E. Hiratsuka Y, et al. Among authors: shimizu m. Support Care Cancer. 2023 Oct 16;31(12):632. doi: 10.1007/s00520-023-08099-2. Support Care Cancer. 2023. PMID: 37843639 Free PMC article.
[Hydromorphone in Cancer Patients-A Retrospective Study].
Sato N, Satomi E, Yoshida T, Shimizu M, Kiuchi D, Ishiki H. Sato N, et al. Among authors: shimizu m. Gan To Kagaku Ryoho. 2020 Dec;47(12):1687-1690. Gan To Kagaku Ryoho. 2020. PMID: 33342984 Japanese.
Cancer Pain Management in Patients Receiving Inpatient Specialized Palliative Care Services.
Tagami K, Chiu SW, Kosugi K, Ishiki H, Hiratsuka Y, Shimizu M, Mori M, Kubo E, Ikari T, Arakawa S, Eto T, Shimoda M, Hirayama H, Nishijima K, Ouchi K, Shimoi T, Shigeno T, Yamaguchi T, Miyashita M, Morita T, Inoue A, Satomi E. Tagami K, et al. Among authors: shimizu m. J Pain Symptom Manage. 2024 Jan;67(1):27-38.e1. doi: 10.1016/j.jpainsymman.2023.09.015. Epub 2023 Sep 18. J Pain Symptom Manage. 2024. PMID: 37730073
The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: a multicenter prospective observational study.
Shimizu M, Maeda I, Kessoku T, Ishiki H, Matsuura T, Hiratsuka Y, Matsuda Y, Hasegawa T, Imai K, Oyamada S, Satomi E; Phase-R OIC Study Group. Shimizu M, et al. Support Care Cancer. 2024 Jul 10;32(8):504. doi: 10.1007/s00520-024-08716-8. Support Care Cancer. 2024. PMID: 38985364
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927-5. Online ahead of print. Lancet. 2024. PMID: 39706209
6,021 results